GT Biopharma Inc - fluxo de caixa (NASDAQ:GTBP) | MetaTrader

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Cash from operating activities -7.26 M-15.61 M-15.22 M-8.85 M-12.9 M-12.91 M -12.91 M Cash from investing activities 0-23.04 M12.14 M-2.01 M12.89 M0 0 Cash from financing activities 12.53 M42.32 M-224 K6.27 M2.98 M15.78 M 15.78 M Free cash flow -7.26 M-15.61 M-15.22 M-8.85 M-12.9 M-12.91 M -12.91 M

Notícias

GT Biopharma firma acordo com Universidade de Minnesota para ensaio de fase 1

GT Biopharma vai reapresentar demonstrações financeiras de 2025 após erro contábil em Direitos Greenshoe

GT Biopharma to restate 2025 financials after error in Greenshoe Rights accounting

GT Biopharma submite pedido de IND para tratamento de câncer de tumor sólido

GT Biopharma submits IND application for solid tumor cancer treatment

EXCLUSIVE: GT Biopharma Plans 2026 Trial For New Cancer Treatment - GT Biopharma (NASDAQ:GTBP)

Ações da GT Biopharma sobem com avanço do estudo de Fase 1 para dose mais alta

GT Biopharma stock rises as Phase 1 trial advances to higher dose

Why Quantum Computing Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket - Cycurion (NASDAQ:CYCU), Clearwater Analytics Hldg (NYSE:CWAN)

GT Biopharma advances to Cohort 4 in Phase 1 trial of cancer therapy

Why Richardson Electronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Apogee Therapeutics (NASDAQ:APGE), Ambow Education Holding (AMEX:AMBO)

EXCLUSIVE: GT Biopharma Reports Progresses Phase 1 Trial Of Lead Drug Candidate For Blood Cancers - GT Biopharma (NASDAQ:GTBP)